| Literature DB >> 29933250 |
Teruhiko Imamura1, Ann Nguyen1, Ben Chung1, Daniel Rodgers1, Nitasha Sarswat1, Gene Kim1, Jayant Raikhelkar1, Sirtaz Adatya1, Takeyoshi Ota1, Tae Song1, Colleen Juricek2, Jerry D Estep3, Daniel Burkhoff4, Valluvan Jeevanandam2, Gabriel Sayer1, Nir Uriel1.
Abstract
The relationship between the HeartMate II left ventricular assist device (LVAD) position and pump thrombosis has been reported. However, further clinical implications of device position are unknown. This study aimed to investigate optimal device position for better left ventricular (LV) unloading and patient prognosis. Patients undergoing a ramp test with right heart catheterization after HeartMate II LVAD implantation were enrolled to this study. Device position was quantified from the chest X-ray obtained at the time of the ramp test: (1) inflow cannula angle relative to horizontal line, (2) pump angle relative to spine, (3) pump depth, (4) angle between inflow cannula and pump, and (5) angle between pump and outflow graft. LV unloading was assessed by pulmonary capillary wedge pressure at set LVAD speed. Fifty-four patients (60 years old and 34 male [63%]) were enrolled. Nobody experienced device malfunction during the study period. Increased LV unloading (i.e., lower pulmonary capillary wedge pressure) was associated with a narrower inflow cannula angle relative to horizontal line. Inflow cannula angle <75° was associated with higher 1 year heart failure readmission-free survival rate (p < 0.05, hazards ratio 7.56 [95% confidence interval 2.32-24.7]). In conclusion, HeartMate II LVAD inflow cannula position was associated with LV unloading and patient prognosis. Prospective studies to ensure optimal device positioning and target better clinical outcomes are warranted.Entities:
Mesh:
Year: 2019 PMID: 29933250 PMCID: PMC6342671 DOI: 10.1097/MAT.0000000000000823
Source DB: PubMed Journal: ASAIO J ISSN: 1058-2916 Impact factor: 2.872